Miniaturized all-in-one microneedle device for point of care light therapy

Huiting Zhao,Xu Wang,Jiyuan Xiong,Guomin Liang,Xin Wu,Jiyu Xi,Yu Zhang,Zixi Li,Xiaoming Hu,Zewen Wei
DOI: https://doi.org/10.1038/s41528-024-00317-z
IF: 14.6
2024-05-30
npj Flexible Electronics
Abstract:Light therapies have been applied to millions of patients for treating many kinds of diseases, especially superficial ones. Currently, mainstream light therapies utilize the combined effects of photosensitizers and light to either remove disordered tissue or promote the growth of healthy tissue. Adverse effects of light therapy, including metabolic burden caused by circulatory photosensitizer and skin damage induced by high irradiance light, are yet to be addressed. This study provides a Miniaturized all-in-one Light therapy Device (MiLD). All components required for light therapy, including dual-function microneedles, LED array, control circuit, and battery are integrated together to form a miniaturized portable device with 2 cm in length, 1.7 cm in width, 1.2 cm in height, and 3.6 g in weight. The all-in-one design and patch-to-cure operation of MiLD enables the successful demonstration of point-of-care light therapy. Satisfactory therapeutic effects have been verified in mice on both types of light therapy. Meanwhile, transdermally co-delivering both photosensitizer and light in situ fully avoids photosensitizer accumulation in blood and remarkably reduces the irradiance of light, therefore significantly alleviating metabolic burden and light-induced skin damage. Overall, the MiLD lays the technical foundation of point-of-care light therapy with its miniaturized all-in-one design, simple patch-to-cure operation, satisfactory therapeutic effects, and minimum adverse effects.
materials science, multidisciplinary,engineering, electrical & electronic
What problem does this paper attempt to address?
The problems that this paper attempts to solve are several major challenges in the process of phototherapy, including: 1. **Metabolic burden**: The current mainstream phototherapy methods use intravenous injection of photosensitizers, which will lead to the accumulation of photosensitizers in the blood circulation system, increase the burden on the metabolic system, and may damage healthy tissues. 2. **Skin damage**: Direct irradiation of the skin with high - irradiance light may cause immediate pain and tissue damage. 3. **Equipment limitations**: Devices that generate high - irradiance light are usually bulky and costly, limiting their availability in primary medical institutions. 4. **Treatment inconvenience**: Patients need to travel to and from the hospital frequently for multiple treatments, which is not only inconvenient but also reduces patient compliance. To address these challenges, the research team has developed a miniaturized all - in - one light therapy device (MiLD). This device integrates dual - function microneedles, LED arrays, control circuits, and batteries to form a portable small device. The design features of MiLD are as follows: - **Dual - function microneedles**: The tips of the microneedles can be dissolved to release photosensitizers, while the transparent needle bodies are used to guide the treatment light into the target tissue. - **Portability**: The device is only 2 cm long, 1.7 cm wide, and 1.2 cm high, and weighs only 3.6 grams, making it easy to carry and use. - **Wireless remote control**: Through Bluetooth wireless connection, the operation of the device can be remotely controlled to achieve simple patch - type treatment operations. Through these designs, MiLD can effectively avoid the accumulation of photosensitizers in the blood, significantly reduce light - induced skin damage, and at the same time provide a convenient point - to - point phototherapy solution. The experimental results show that MiLD has successfully achieved two types of phototherapy in a mouse model and has shown satisfactory treatment effects in removing diseased tissues while minimizing adverse reactions.